Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase

Journal of Lipid Research

Volumn 46, Issue 10, 2005, Pages 2083-2090

  Moore, Zachary W Q ^a   Hui, David Y ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Endothelial denudation; Neointimal hyperplasia; Smooth muscle cells; Transgenic mice; Vascular biology

Indexed keywords

APOLIPOPROTEIN E; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERPLASIA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; THICKNESS; TRANSGENIC MOUSE; VASCULAR DISEASE;

AMIDINES; ANIMALS; APOLIPOPROTEINS E; BENZYLAMINES; CAROTID ARTERY INJURIES; HYPERPLASIA; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, TRANSGENIC; NITRIC OXIDE SYNTHASE TYPE II; TUNICA INTIMA;

EID: 25444437566     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500177-JLR200     Document Type: Article

References (30)

1. Stary, H. C., A. B. Chandler, R. E. Dinsmore, V. Fuster, S. Glagov, W. Insull, M. E. Rosenfeld, C. J. Schwartz, W. D. Wagner, and R. W. Wissler. 1995. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15: 1512-1531.
2. Li, S., Y-S. Fan, L. H. Chow, C. Van den Diepstraten, E. van der Veer, S. M. Sims, and J. G. Pickering. 2001. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ. Res. 89: 517-525.
3. Schwartz, R. S., and T. D. Henry. 2002. Pathophysiology of coronary artery restenosis. Rev. Cardiovasc. Med. 5 (Suppl.): 4-9.
4. Kearney, M., A. Pieczek, L. Haley, D. W. Losordo, V. Andres, R. Schainfeld, K. Rosenfield, and J. M. Isner. 1997. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation. 95: 1998-2002.
5. Wilensky, R. L., K. L. March, I. Gradus-Pizlo, G. Sandusky, N. Fineberg, and D. R. Hathaway. 1995. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation. 92: 2995-3005.
6. Reidy, M. A. 1992. Factors controlling smooth muscle cell proliferation. Arch. Pathol. Lab. Med. 116: 1276-1280.
7. Schwartz, S. M. 1997. Smooth muscle migration in atherosclerosis and restenosis. J. Clin. Invest. 11 (Suppl.): 87-89.
8. Zhu, B., D. G. Kuhel, D. P. Witte, and D. Y. Hui. 2000. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am. J. Pathol. 157: 1839-1848.
9. Wientgen, H., F. E. Thorngate, S. Omerhodzic, L. Rolnitzky, J. T. Fallo, D. L. Williams, and E. A. Fisher. 2004. Subphysiologic apolipoprotein E (apoE) plasma levels inhibit neointimal formation after arterial injury in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 24: 1460-1465.
10. Moore, Z. W. Q., B. Zhu, D. G. Kuhel, and D. Y. Hui. 2004. Vascular apolipoprotein E expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation. Am. J. Pathol. 164: 2109-2116.
11. Ishigami, M., D. K. Swertfeger, N. A. Granholm, and D. Y. Hui. 1998. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J. Biol. Chem. 273: 20156-20161.
12. Ishigami, M., D. K. Swertfeger, M. S. Hui, N. A. Granholm, and D. Y. Hui. 2000. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 20: 1020-1026.
13. Swertfeger, D. K., G. Bu, and D. Y. Hui. 2002. Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. J. Biol. Chem. 277: 4141-4146.
14. Zhu, Y., and D. Y. Hui. 2003. Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J. Biol. Chem. 278: 36257-36263.
15. Swertfeger, D. K., and D. Y. Hui. 2001. Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation. J. Biol. Chem. 276: 25043-25048.
16. Kothapalli, D., I. Fuki, K. Ali, S. A. Stewart, L. Zhao, R. Yahil, D. Kwiatkowski, E. A. Hawthorne, G. A. FitzGerald, M. C. Phillips, et al. 2004. Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation. J. Clin. Invest. 113: 609-618.
17. Zhu, B., C. A. Reardon, G. S. Getz, and D. Y. Hui. 2002. Both apolipoprotein E and immune deficiency exacerbate neointimal hyperplasia after vascular injury in mice. Arterioscler. Thromb. Vasc. Biol. 22: 450-455.
18. Garvey, E. P., J. A. Oplinger, E. S. Furfine, R. J. Kiff, F. Laszlo, B. J. R. Whittle, and R. G. Knowles. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272: 4959-4963.
19. Sarkar, R., E. G. Meinberg, J. C. Stanley, D. Gordon, and R. C. Webb. 1996. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78: 225-230.
20. Lee, J. S., C. Adrie, H. J. Jacob, J. D. Roberts, Jr., W. M. Zapol, and K. D. Bloch. 1996. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ. Res. 78: 337-342.
21. Van, Z-Q., T. Yokota, W. Zhang, and G. K. Hansson. 1996. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ. Res. 79: 38-44.
22. Ziehe, M., L. Morbidelli, E. Masini, S. Smerini, H. J. Granger, C. A. Maggi, P. Geppetti, and F. Ledda. 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94: 2036-2044.
23. Kuhlencordt, P. J., J. Chen, F. Han, J. Astern, and P. L. Huang. 2001. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation. 103: 3099-3104.
24. Ihrig, M., C. A. Dangler, and J. G. Fox. 2001. Mice lacking inducible nitric oxide synthase develop spontaneous hypercholesterolemia and aortic atheromas. Atherosclerosis. 156: 103-107.
25. Chyu, K. Y., P. Dimayuga, J. Zhu, J. Nilsson, S. Kaul, P. K. Shah, and B. Cercek. 1999. Decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice. Circ. Res. 85: 1192-1198.
26. Koglin, J., T. Glysing-Jensen, J. S. Mudgett, and M. E. Russell. 1998. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation. 97: 2059-2065.
27. Kuhel, D. G., B. Zhu, D. P. Witte, and D. Y. Hui. 2002. Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler. Thromb. Vasc. Biol. 22: 955-960.
28. Laubach, V. E., E. G. Shesely, O. Smithies, and P. A. Sherman. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. USA. 92: 10688-10692.
29. Sarkar, R., D. Gordon, J. C. Stanley, and R. C. Webb. 1997. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am. J. Physiol. 272: H1810-H1818.
30. Yu, S. M., L. M. Hung, and C. C. Lin. 1997. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. Circulation. 95: 1269-1277.